Primary fatty acid amides (PFAMs) are important signaling molecules in the mammalian nervous system, binding to many drug receptors and demonstrating control over sleep, locomotion, angiogenesis, and many other processes. Oleamide is the best-studied of the primary fatty acid amides, while the other known PFAMs are significantly less studied. Herein, 
INTRODUCTION

5
this group of molecules. Given there are multiple pathways known for the biosynthesis of the NAEs (44) (45) (46) , it is likely that there are also multiple routes for the in vitro production of the NAGs and the PFAMs (29, 30) . In fact, Bradshaw et al. (46) have shown that the NAGs are produced in the C6 glioma cells via both the glycine-dependent and NAE-dependent reactions shown in Fig. 1 .
The N 18 TG 2 cells produce oleamide and are known to express PAM and FAAH (36, 47, 48) . Oleamide has been the focus of the PFAM research in the N 18 TG 2 cells and one goal of the work detailed herein was to broaden the scope of the N 18 TG 2 -based work to other PFAMs.
It is essential to determine if the pathways defined for oleamide biosynthesis and degradation would account for the other known PFAMs. Our other goals were to establish the choroid plexus cells as another model system for PFAM metabolic studies and that the NAEs are precursors for the PFAMs.
We report here, for the first time, the N 18 TG 2 -mediated conversion of a series of fatty acids to PFAMs, including the production of tridecanamide from N-tridecanoylethanolamine.
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MATERIALS AND METHODS
Materials and Chemicals
Linoleic acid, palmitic acid, 6-thioguanine, and fatty acid-free bovine serum albumin (BSA) were from Sigma, elaidic acid and palmitoleic acid were from Fisher, penicillin/streptomycin, EMEM, and DMEM were supplied by Mediatech Cellgro, fetal bovine serum (FBS) was from Atlanta Biologicals, BSTFA and silica were from Suppelco, 
BSA as a Fatty Acid Carrier
BSA was used as a carrier for fatty acids in aqueous media. Fatty acids were dissolved in ethanol, converted to the sodium salt with excess NaOH, dried under vacuum, and dissolved in phosphate-buffered saline (PBS) to make a 25 mM solution. FBS media, but were collected in 10% FBS media under normal growing conditions. A set of control experiments were carried using cells grown in 0.5% FBS media.
Organic Solvent Extraction of the Lipid Metabolites
Metabolites were extracted from cells using procedures similar to those described by Sultana and Johnson (50) . Methanol (4 mL) was added to the cell pellets and the resulting mixture was sonicated for 15 min at room temperature. The samples were then centrifuged to 
Solid Phase Extraction of the Lipid Metabolites
Silica columns (0.5 g) were washed with n-hexane and run essentially as described by Sultana and Johnson (50) . The dried lipid extracts, prepared as described above, were redissolved in 100 µL n-hexane and applied to a washed silica column. To test effectiveness of the extraction methods, cells and media were spiked with each PFAM and subjected to the organic solvent extraction and solid phase extraction procedures before GC-MS quantification. Percent recoveries ranged from 82-101%.
Gas Chromatography -Mass Spectrometry (GC-MS)
All separations were performed using a Shimadzu QP-5000 GC-MS. Separations were 
Controls
Some PFAMs, particularly oleamide and erucamide, are used as slip additives in polyethylenes (51) (52) (53) . Thus, background PFAM levels must be determined due to potential slip additive contamination. Background PFAM levels were measured by running solvents through all the same glassware and plasticware as used for the cell and media samples, and the collected solvents were subjected to sonication, solid phase extraction, and derivitization. Integration of the GC trace was taken over the same time integral as standard amides and for the same set of
ions. An averaged number of cells were used to calculate blank amount of amide per cell in the blank samples. Unconditioned media was also subjected to extraction and SPE to assay for background amides. Finally, to test for the change in oleamide production, SCP and N 18 TG 2 cells were incubated for 48 hr with media containing 0.5% FBS and 0.25 mM BSA carrier, but no long chain fatty acyl metabolite. Cells and media were both collected and subjected to PFAM analysis as described above.
Data Analysis
Total ion chromatograms (TICs) were collected and, post-run, a set of selected ions unique to the amides and nitriles under examination was overlaid and integrated so that effects of any co-eluting compounds could be minimized. These unique ion sets are based on electronimpact (EI) fragmentation of the PFAMs and nitrile standards and can be found in 
Western Blot Analysis
SDS polyacrylamide gel electrophoresis was run according to the method of Laemmli (54). Transfer from the SDS gels onto a PVDF membrane was carried out at 80 V for 60 min.
To ensure specificity, controls were run with the FAAH antibody preincubated with its blocking peptide prior to Western Blot analysis. Antibodies were incubated with a 50-fold molar excess of the blocking peptide for 2.5 hours at 36 °C with agitation and this was followed by a 2-24 hr.
incubation at 4 °C in 500 L of PBS. The antibodies were then used directly from the PBS solution.
RT-PCR
N 18 TG 2 and SCP cells were isolated from culture (one T-75 cm 2 flask, grown to ~90% of confluency), lysed, and the mRNA isolated using the MicroPoly(A) Pure mRNA purification kit from Ambion. cDNA was generated from the isolated mRNA using the RETROscript reverse transcription kit also from Ambion. PCR conditions were as follows: an initial 3 min denatureation at 95 °C followed by 25-45 cycles of denaturation at 95 °C (1 min), anneling at 45 °C (1 min), and elongation at 72 °C (1 min) with a final elongation cycle of 7 min at 72 °C. The PCR product was gel purified using a QIAQuick gel extraction kit (Qiagen) and the product sequenced.
RESULTS
Analysis of Background PFAMs
Endogenous amounts of the PFAMs were measured to provide a baseline reference level (time = 0), and are shown in Table 2 . The levels of linoleamide, oleamide, palmitamide, palmitoleamide, and tridecanamide isolated from unconditioned media generally represent a small percentage of those isolated from conditioned media. The PFAM levels in the unconditioned media blanks were 1 -6% of those found in media conditioned by the SCP cells and 1 -22% of those found in media conditioned by the N 18 G 2 cells. Linoleamide was an exception, at 44% of that measured from the N 18 TG 2 cell conditioned media.
We also measured PFAM levels in solvents, glassware, and plasticware used in the extractions to measure background amounts from potential slip additives (51) (52) (53) . PFAM levels in the solvent blanks were low, ranging between 0.5 -8% of the amounts isolated from the SCP or N 18 TG 2 cells. Tridecanamide was an exception as the blank value was 18% of that identified from the N 18 TG 2 cells post-incubation.
We have divided the background PFAM levels by the average number of viable cells per experiment (with all the extraction volumes being the same) to enable a direct comparison of the background amounts to those we measured in the cells and the cell-conditioned media (Table 3) . The methods used to measure the levels of the PFAMs could not discriminate oleamide (cis-9-octadecenic acid) and elaidamide (trans-9-octadecenic acid). We have assumed that the background 18:1 amide reported here is oleamide because oleamide is a common slip additive (51, 53) .
Analysis of PFAMs Produced by the N 18 TG 2 Cells
We first measured the amounts of linoleamide, palmitoleamide, palmitamide, and oleamide in the N 18 TG 2 cells before growth in the presence of exogenously added fatty acids.
The C18:1 PFAM identified endogenously is assumed to be oleamide rather than elaidamide.
The reasons are that oleamide and not elaidamide has been identified in N 18 TG 2 cells (36) and that trans-fatty acids are not produced in non-ruminant animals, but are derived from food (55).
The concentrations of the endogenous PFAMs were relatively low, ranging from 100 ± 60 pmoles/10 7 cells for linoleamide to 930 ± 250 pmoles/10 7 cells for palmitamide ( Table 2 ). Upon growth of the N 18 TG 2 cells in the presence of exogenously added fatty acids (using BSA as a carrier), the corresponding PFAM was identified from both the cells and the N 18 TG 2 cellconditioned media (Table 4 ). Statistical analysis of the PFAM production data to define the robustness of the measured differences in the PFAM levels is included in Tables S1 and S2 (Supplementary Material). In most cases, the amount of PFAM found in the conditioned media was similar to the amount isolated from the washed cells. Incubation of the N 18 TG 2 cells for 0, 12, 24 or 48 hr in the presence of exogenously added fatty acids leads to continued production of the corresponding PFAM (Table 4 , Fig. 2A , and 
Analysis of PFAMs Produced by the SCP Cells
Incubation of the SCP cells with each fatty acid lead to the production of corresponding PFAM (Figs. 2B and 2D), including the non-naturally occurring tridecanamide. In most cases, the amount of PFAM found in the conditioned media was similar to the amount of PFAM found in the cells themselves (Table 4) , as was seen for N 18 TG 2 cells. The amounts of amides found from the SCP cells and in the SCP conditioned media after 0, 12, 24 or 48 hours incubation with corresponding fatty acids can be found in Table 3 and Figs. 2B and 2D. Overall, higher levels of the PFAMs were identified from the SCP cells and SCP cell-conditioned media relative to those measured for the N 18 TG 2 cells and N 18 TG 2 cell-conditioned media. Note that oleamide was the most abundant PFAM produced by the SCP cells.
As was observed in the N 18 TG 2 cells, we found that tridecanamide was produced by the SCP cells from both tridecanoate and N-tridecanoyethanolamine (Table 4 , Fig. 3B , and Fig. 3D ).
This is the first report of the conversion of an NAE to a PFAM in the SCP cells.
Controls for the Time-Dependent Production of Oleamide in the N 18 TG 2 and SCP Cells
To insure that the increasing amounts of the PFAMs we measured over time (Table 4 and (Table 4 ) and that found in cells incubated for 48 hr with BSA and low serum media only (data not shown).
A set of cell-free controls were run to test for the formation of PFAMs in media.
Mueller and Driscoll (56) or N-oleoylethanolamine for 48 hr. We found no significant difference between the amount of oleamide present in the blank controls and media (both conditioned and unconditioned) exposed to oleoyl metabolites.
FAAH Expression Studies
The PFAM levels produced in the SCP cells is generally higher than that found in N 18 TG 2 cells (Table 4) There are a few discernible patterns when comparing the PFAM quantification data from or between the two cell lines. In general, the levels of the endogenous PFAMs are higher in the SCP cells. This is most evident for oleamide, for which the endogenous level in the SCP cells is ~50-fold higher than in the N 18 TG 2 cells (6400 pmoles per 10 7 cells vs. 120 pmoles per 10 7 cells, see Table 2 ). The endogenous PFAM levels reflect a steady-state balance between production, degradation, and secretion, and are also likely influenced by the fatty acids and other fatty acidcontaining moieties of the growth medium.
As was observed with the endogenous PFAM levels, there are a few obvious patterns in comparing PFAM production data (in cells and excreted into the media) in the two cell lines.
Similar to the endogenous PFAM levels, total PFAM production is generally higher for the SCP cells, ranging from ~4-fold higher for tridecanamide to ~40-fold for linoleamide.
Palmitoleamide and palmitamide are exceptions with ~2-fold higher amounts produced by the by guest, on November 9, 2017 www.jlr.org Downloaded from N 18 TG 2 cells relative to the SCP cells. In comparing the amounts of the specific PFAMs that were produced, the elaidamide levels were consistently higher than the oleamide levels and tridecanamide was always the lowest in the two cell lines (whether produced from the tridecanoate or N-tridecanoylethanolamine). One likely reason for the higher levels of total PFAM production in the SCP cells is the lack of detectable FAAH expression in these cells (Fig.   4 and ref. 58 ). These data and higher endogenous PFAM levels in the SCP cells (Table 2) We identified and quantified tridecanamide in the model cell lines after incubation with N-tridecanoylethanolamine (Fig. 3) . This is the first report of the conversion of an NAE to the corresponding PFAM in the N 18 TG 2 and SCP cells, providing additional evidence for the NAEs serving as precursors to the PFAMs. The levels of tridecanamide produced from N-tridecanoylethanolamine were higher than that produced by tridecanoate in the SCP cells. The differences in overall production of tridecanamide between the SCP and N 18 TG 2 cells could result from differences in the rates of tridecanoate being converted into phospholipids in the two cells. Nonetheless, it is intriguing that the SCP cells, which do not express FAAH (Fig. 4) , produce a higher level of tridecanamide suggesting that FAAH plays a major role in the cellular degradation of the NAEs.
In conclusion, five endogenous PFAMs were found in N 18 TG 2 and SCP cells, all of which are new findings (except for oleamide in N 18 TG 2 ). The amount of endogenous PFAMs This value actually represents the sum of the background levels of oleamide and elaidamide.
Background levels of elaidamide (trans-9-octadecenic acid) are most likely ~0 (51, 53) . 
